IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $5,039,000 | -42.7% | 373,785 | -10.0% | 0.08% | +13.0% |
Q4 2019 | $8,792,000 | +73.2% | 415,519 | +8.6% | 0.07% | +72.5% |
Q3 2019 | $5,076,000 | -8.4% | 382,773 | -4.2% | 0.04% | -2.4% |
Q2 2019 | $5,540,000 | -37.3% | 399,400 | -13.2% | 0.04% | -34.9% |
Q1 2019 | $8,836,000 | +46.4% | 459,956 | +8.8% | 0.06% | +34.0% |
Q4 2018 | $6,035,000 | -9.3% | 422,934 | +32.4% | 0.05% | +6.8% |
Q3 2018 | $6,651,000 | +16.2% | 319,322 | +32.0% | 0.04% | +18.9% |
Q2 2018 | $5,725,000 | +76.2% | 241,871 | +8.8% | 0.04% | +42.3% |
Q1 2018 | $3,249,000 | +19.4% | 222,353 | +32.0% | 0.03% | +36.8% |
Q4 2017 | $2,722,000 | – | 168,456 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |